-
Active Trials
-
Phase 3
-
Phase 2
-
Phase 1
-
Results Pending
π
Pipeline Summary
Expected Approvals
FDA Decision 1 upcoming PDUFA date
bictegravir and lenacapavir (BIC LEN) virologically suppressed people with HIV NDA
Clinical Trials
Loading...